Infinity Natural Resources Q2 Revenue Increases-March 2024-www.financetom.com

Infinity Natural Resources Q2 Revenue Increases

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Infinity Natural Resources Q2 Revenue Increases

Aug 11, 2025 2:49 PM

05:15 PM EDT, 08/11/2025 (MT Newswires) -- Infinity Natural Resources ( INR ) reported Q2 earnings Monday of $1.18 per diluted share.

Analysts polled by FactSet expected $0.42.

The company went public in early 2025, and comparable per-share figures for the prior-year quarter were not reported.

Revenue for the quarter ended June 30 was $74.5 million, up from $70.4 million a year earlier.

Analysts surveyed by FactSet expected $82.4 million.

Shares of Infinity Natural Resources ( INR ) were up 1.7% in after-hours trading.

Previous page： Next page： Blackstone selling Japan drugmaker Alinamin to MBK Partners

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Jul 2, 2024

...

Blackstone selling Japan drugmaker Alinamin to MBK Partners

Jul 2, 2024

TOKYO, July 3 (Reuters) - Blackstone and MBK Partners said on Wednesday the U.S. private equity firm is selling Japanese drugmaker Alinamin Pharmaceutical to the North Asian buyout fund. The deal size would be 350 billion yen ($2.17 billion), a source said on Tuesday, however neither Blackstone nor MBK in their separate statements disclosed the transaction value. Blackstone acquired Alinamin...

BRIEF-Aviat Networks Acquires 4Rf

Jul 2, 2024

July 2 (Reuters) - Aviat Networks Inc ( AVNW ): * AVIAT NETWORKS ACQUIRES 4RF, A LEADING PROVIDER OF INDUSTRIAL WIRELESS ACCESS SOLUTIONS FOR CRITICAL INFRASTRUCTURE * AVIAT NETWORKS ( AVNW ) - TERMS OF ACQUISITION WERE NOT DISCLOSED Source text for Eikon: Further company coverage: ...

Blackstone selling Japan drugmaker Alinamin to MBK Partners

Jul 2, 2024

TOKYO (Reuters) - Blackstone and MBK Partners said on Wednesday the U.S. private equity firm is selling Japanese drugmaker Alinamin Pharmaceutical to the North Asian buyout fund. The deal size would be 350 billion yen ($2.17 billion), a source said on Tuesday, however neither Blackstone nor MBK in their separate statements disclosed the transaction value. Blackstone acquired Alinamin in 2020...